Author

M. A. Taylor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Balmain· 1 shared A. Basnakian· 1 shared B. M. Nagalo· 1 shared C. C. Simoes· 1 shared C. Dumbauld· 1 shared D. Quigley· 1 shared D. Wu· 1 shared E. Kandyba· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Balmain

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gene networks reveal stem-cell state convergence during preneoplasia and progression to malignancy in multistage skin carcinogenesis

M. A. Taylor, E. Kandyba, K. Halliwell, R. Del Rosario, M. S. Khoroshkin, H. Goodarzi, D. Quigley, Y. R. Li, D. Wu, S. Bollam, O. Mirzoeva, R. Akhurst, A. Balmain

The paper identifies gene networks driving cancer progression by analyzing stem-cell states in mouse skin carcinogenesis and links them to drug resistance and immune surveillance in human tumors.

bioRxiv · May 8, 2023 · PreprintCancer Biology

Repurposing Live Attenuated Trivalent MMR Vaccine as Cost-effective Cancer Immunotherapy

B. M. Nagalo, Y. Zhang, M. A. Taylor, C. C. Simoes, C. Dumbauld, M. N. Gabere, O. Barro, J. C. Chamcheu, S. R. Post, T. J. Kelly, M. J. Borad, M. J. Cannon, A. Basnakian

This study shows that intratumoral MMR vaccine injections inhibit tumor growth and improve survival in mouse cancer models by enhancing cytotoxic T-cell responses.

bioRxiv · Feb 25, 2022Immunology